ERI-1 Inhibitors

ERI-1 inhibitors encompass a broad range of chemicals that exert their influence primarily by modifying the availability, processing, or stability of RNA substrates upon which ERI-1 can act. These compounds, such as α-Amanitin and Actinomycin D, either directly inhibit RNA polymerases or bind to DNA, leading to the disruption of RNA synthesis. This reduction in RNA synthesis indirectly impacts ERI-1's role in RNA degradation.

Other compounds, like Cordycepin and 5-Azacytidine, are nucleoside analogs that integrate into RNA chains. Their incorporation can affect the overall stability, processing, and structure of RNA, potentially altering the substrates available for ERI-1-mediated degradation. Additionally, compounds like Caffeine and Camptothecin might produce broader cellular effects that indirectly modulate RNA-centric pathways, further influencing ERI-1's activity. Together, these chemicals offer diverse mechanisms by which ERI-1's function in the cell can be modulated.